Global Health Investment Corporation

GHIC Selected to 2026 ImpactAssets 50 Fund Managers

March 10, 2026

GHIC is thrilled to announce its selection to the ImpactAssets 50 (IA 50) for the second year in a row. For 15 years, the IA 50 has recognized a diverse group of private markets impact fund managers that are committed to generating positive impact. Explore the IA 50.

About the ImpactAssets 50

ImpactAssets 50® (IA 50) is the definitive guide to impact investing fund managers globally. The publicly available database is composed of experienced and emerging private debt and equity impact investment fund managers committed to generating positive impact. The IA 50 2025 reflects the innovation and exponential growth of impact investing that the IA 50 has helped to spotlight over last 15 years. The IA 50 is not an index or investable platform and does not constitute an offering or solicitation to buy or sell securities or a private placement, or recommend specific products. Nor is this an endorsement of any of the listed fund managers. It is not a replacement for due diligence. Additional details on the selection process are available here.

About Global Health Investment Corporation (GHIC)

A pioneer of investing in global health, GHIC has been supporting high-impact biomedical innovations for over a decade. GHIC's Global Health Investment Fund (GHIF) financed the development of products to combat public health challenges that disproportionately affect people living in low- and middle-income countries. In 2021, GHIC entered a 10-year venture investment partnership with the Biomedical Advanced Research and Development Authority (BARDA) focused on global health security.